Form EFFECT Cingulate Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 24, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cingulate receives first U.S. patent for ADHD drug candidate CTx-1301
- Enstar Group Limited Announces Pricing of $500 Million of 6.693% Fixed-to-Floating Rate Junior Subordinated Notes Due 2037
- EVA Air's In-Flight Wines Earn Double Gold at 2026 Cellars in the Sky Awards
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
